Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Leukemia 9Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Myelodysplastic Syndromes 5Multiple Myeloma 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Burkitt Lymphoma 4Tumor Lysis Syndrome 3Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Prolymphocytic 3Hodgkin Disease 3Neoplasms 2Myeloproliferative Disorders 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hyperuricemia 2HIV Infections 2Congenital Abnormalities 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1

Interventions

Doxorubicin 18Vincristine 15Zidovudine 11Bleomycin 11Cyclophosphamide 9Etoposide 8Interferon alpha-2 6Prednisone 5Cytarabine 5tecogalan 4sargramostim 4Rituximab 4Polymerase Chain Reaction 4Liposomes 4Filgrastim 4Dexamethasone 4Methotrexate 3Leucovorin 3Fluorouracil 3interferon alfa-n1 2Watchful Waiting 2Vinblastine 2Tumor Necrosis Factor-alpha 2Thalidomide 2Semaxinib 2Ritonavir 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Light Coagulation 2Isotretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × HIV Infections × Allopurinol × Clear all
NCT00000658 2021-11-03

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
250 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections

NCT00000703 2021-11-03

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Completed
45 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡